Free Trial

GoodRx (GDRX) News Today

$7.27
+0.13 (+1.82%)
(As of 05/28/2024 ET)
GoodRx: Encouraging Profit Stabilization (Rating Upgrade)
GoodRx (NASDAQ:GDRX) Shares Gap Up to $7.20
GoodRx (NASDAQ:GDRX) Upgraded at Royal Bank of Canada
Royal Bank of Canada raised GoodRx from a "sector perform" rating to an "outperform" rating and upped their price objective for the stock from $8.00 to $10.00 in a report on Thursday.
GoodRx (NASDAQ:GDRX) Stock Price Up 2.8% After Analyst Upgrade
GoodRx (NASDAQ:GDRX) Stock Price Up 2.8% Following Analyst Upgrade
GoodRx (NASDAQ:GDRX) Given New $10.00 Price Target at Barclays
Barclays lifted their target price on shares of GoodRx from $9.00 to $10.00 and gave the company an "overweight" rating in a research note on Monday.
GoodRx (NASDAQ:GDRX) Stock Price Down 4.5%
Jump Financial LLC Purchases 125,028 Shares of GoodRx Holdings, Inc. (NASDAQ:GDRX)
Jump Financial LLC grew its position in GoodRx Holdings, Inc. (NASDAQ:GDRX - Free Report) by 568.7% during the fourth quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 147,011 shares of the company's stock after buying an additional 125,028 shares duri
GoodRx (NASDAQ:GDRX) Shares Down 4.5%
GoodRx (NASDAQ:GDRX) Stock Price Down 4.5%
GoodRx (NASDAQ:GDRX) Shares Gap Up on Analyst Upgrade
GoodRx (NASDAQ:GDRX) Shares Gap Up Following Analyst Upgrade
TD Cowen Increases GoodRx (NASDAQ:GDRX) Price Target to $16.00
TD Cowen boosted their price objective on shares of GoodRx from $14.00 to $16.00 and gave the company a "buy" rating in a research report on Thursday.
KeyBanc Remains a Buy on GoodRx Holdings (GDRX)
GoodRx (NASDAQ:GDRX) Rating Increased to Outperform at Raymond James
Raymond James raised shares of GoodRx from a "market perform" rating to an "outperform" rating and set a $10.00 price objective for the company in a research report on Thursday.
GoodRx (NASDAQ:GDRX) Trading 7.4% Higher
GoodRx (NASDAQ:GDRX) Stock Price Up 7.4%
Get GoodRx News Delivered to You Automatically

Sign up to receive the latest news and ratings for GDRX and its competitors with MarketBeat's FREE daily newsletter.

Obama’s Forever Term [exposed] (Ad)

Over a decade ago, I tried to warn you... Because the same forces are once again brewing… and what’s coming next will forever reshape everything you think you know about America.

Start streaming it now at no cost here

GDRX Media Mentions By Week

GDRX Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

GDRX
News Sentiment

0.41

0.82

Average
Medical
News Sentiment

GDRX News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

GDRX Articles
This Week

21

5

GDRX Articles
Average Week

Get GoodRx News Delivered to You Automatically

Sign up to receive the latest news and ratings for GDRX and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

This page (NASDAQ:GDRX) was last updated on 5/29/2024 by MarketBeat.com Staff

From Our Partners